Background: Beta-amyloid (Aβ) protein is a key factor in the pathogenesis of Alzheimer's disease (AD) and it has been reported that mitochondria is involved in the biochemical pathway by which Aβ can lead to neuronal dysfunction. Coenzyme Q10 (CoQ10) is an essential cofactor involved in the mitochondrial electron transport chain and has been suggested as a potential therapeutic agent in AD. Zinc toxicity also affects cellular energy production by decreasing oxygen consumption rate (OCR) and ATP turnover in human neuronal cells, which can be restored by the neuroprotective effect of docosahexaenoic acid (DHA). Method: In the present study, using Seahorse XF-24 Metabolic Flux Analysis we investigated the effect of DHA and CoQ10 alone and in combination against Aβ-and zinc-mediated changes in the mitochondrial function of M17 neuroblastoma cell line. Results: Here, we observed that DHA is specifically neuroprotective against zinc-triggered mitochondrial dysfunction, but does not directly affect Aβ neurotoxicity. CoQ10 has shown to be protective against both Aβ-and zincinduced alterations in mitochondrial function. Conclusion: Our results indicate that DHA and CoQ10 may be useful for the prevention, treatment and management of neurodegenerative diseases such as AD.
Introduction
The omega-3 fatty acid docosahexaenoic acid (DHA) is the major polyunsaturated fatty acid (PUFA) in the phospholipid fractions of the brain and is required for normal cellular function [1] . Structurally, DHA comprises 22 carbons and six double bonds, making it the most unsaturated fatty acid in cell membranes and important for increasing the fluidity of cell membranes [2] . Increased DHA in cell membranes lowers the susceptibility to lipid peroxidation and oxidative stress in neuronal cells [3] . Therefore, increased intake of DHA is reported to significantly reduce the incidence of neurodegenerative diseases, such as Alzheimer's disease [4, 5] . Previous data has shown that reduced DHA levels in AD brains were associated with an increase in intracellular zinc levels [6] , which could suggest a direct interaction between DHA and zinc in the progression of AD. Zinc-mediated brain injury has been implicated as a neurotoxin in models of AD [7] . However, the mechanism of zinc toxicity is unknown, but evidence suggests that zinc induces cellular apoptosis through inhibition of adenosine triphosphate (ATP) synthesis [8, 9] , increase in the production of reactive oxygen species (ROS) and eventual loss of mitochondrial membrane potential ∆Ψ m [9] . Recently, we reported that DHA protects against zinc-mediated alterations in human neuronal cell bioenergetics and mitochondrial function [10] .
AD is characterized by the accumulation of amyloid-beta (Aβ)-containing plaques, hyperphosphorylated neurofibrillary tangles, neuronal death and synaptic loss [11, 12] . Impaired mitochondrial function [12] and a decrease in membrane potential ∆Ψ m have also been recognized as early events within the Aβ toxicity cascade [13] . Coenzyme Q10 (CoQ10), a component of the mitochondrial electron transport chain, is well characterized as a neuroprotective antioxidant in human neuronal cells [14] , as well as in animal models [15] and human trials of AD [16] . CoQ10 has membrane-stabilizing properties and also plays a vital role in ATP production [17] . Like the omega-3 fatty acid DHA, CoQ10 levels are decreased with aging [18] , and in a number of neurodegenerative conditions [19] .
Both DHA and CoQ10 have demonstrated neuroprotection in human neuronal cells, however it is unclear whether one is better than the other and whether the combined administration of DHA and CoQ10 has additive effects against Aβ-and zinc-induced mitochondrial dysfunction. In this study, we examined whether combined DHA and CoQ10 could preserve bioenergetics and mitochondrial function better than either DHA or CoQ10 alone, in response to Aβ and zinc toxicity in human neuronal cells.
Materials and Methods

Cell culture
Human neuroblastoma M17 cells were cultured in Opti-MEM media (Invitrogen), supplemented with 2.5% heat inactivated fetal bovine serum (FBS), in a humidified incubator at 37 o C with 5% CO 2 . Trypsin/ EDTA (0.05%; Gibco) was used for trypsinization.
For treatment analysis, the growth medium was replaced with experimental media (Opti-MEM) treated with and without beta-amyloid (Aβ 1-42 ) peptide (final concentration 10 nM), zinc (final concentration 5 µM), Coenzyme Q10 (CoQ10) dissolved in acetone (final concentration 10 μM) and docosahexaenoic acid (DHA) (final concentration 30 µM; Nu Chek Prep Inc, Elysian, Mn, USA), in the presence of anti-oxidant vitamin E (final concentration 50 nM).
In order to confirm the extracellular zinc uptake, we have previously tested whether zinc enters M17 human neuroblastoma cells. We observed that zinc does in fact get into cells as shown by our Aldrich (MO, USA) dissolved in dimethyl sulfoxide (DMSO) and stored at -80°C until use. Aβ 1-42 peptide was pre-incubated in DMSO at 37°C overnight prior to experiments to allow aggregation. Unlike water that would promote a quick Aβ aggregation, dissolving Aβ1 -42 peptide in DMSO delays the protein aggregation, so pre-incubation prior to the experiment is necessary [21] . We initially tested a range of Aβ 1-42 peptide concentrations on mitochondrial function and cell viability. 10 nM Aβ 1-42 peptide in DMSO was chosen as our final concentration, as it induced mitochondrial dysfunction without reducing cell viability. This concentration has previously been used to perturb mitochondrial function in other neuronal cell lines [22] .
Seahorse XF-24 Metabolic Flux Analysis M17 neuroblastoma cells were cultured in Seahorse XF-24 (Seahorse Bioscience, Billerica, USA) plates at a density of 25,000 cells per well. Cells were treated with, either the control vehicle, Aβ peptide (10 nM), zinc (5 μM), DHA (30 µM), or CoQ10 (10 μM), alone and in combination for 24 h, prior to analysis. On the day of analysis, cells were changed to unbuffered DMEM (DMEM base medium supplemented with 25 mM glucose, 1 mM sodium pyruvate, 1 mM GlutaMax, pH 7.4) and incubated at 37°C in a non-CO 2 incubator for 1 h. The assay protocol consisted of repeated cycles of 2 min mix, 2 min wait and 4 min measurement periods, with oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measured simultaneously through each measurement period by excitation of fluorophores for O 2 and H + . This gives measurement of oxidative and non-oxidative metabolism, respectively. Three readings were taken after each addition of mitochondrial inhibitor before injection of the subsequent inhibitors. The mitochondrial inhibitors used were the ATP synthase inhibitor oligomycin (final concentration 1 μM), the proton ionophore carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP; 1 μM) and the complex III inhibitor antimycin A (1 μM). Mitochondrial function parameters were determined using these mitochondrial inhibitor compounds as modulators to determine a number of bioenergetic and mitochondrial function parameters, including basal respiration, ATP turnover rate, proton leak and maximal and spare respiratory capacity. All treatment conditions were analyzed as ten replicates across 3 plates and data were pooled to give average values for each treatment. After the assays, plates were saved and protein concentrations for each well were measured.
Intracellular reactive oxygen species (ROS) production (Amplex Red assay)
Intracellular H 2 O 2 production in M17 neuroblastoma cells were determined fluorometrically with the Amplex Red reagent (Molecular Probes, Eugene, OR). Oxidation of Amplex Red coupled by horseradish peroxidase (HRP) causes a reduction of H 2 O 2 which produces the red fluorescent oxidation product, resorufin [23] . Reaction buffer (1X) is comprised of 0.05 M sodium phosphate (pH 7.4) and was prepared from a 5X concentrate supplied by the kit. A 10 mM stock solution of Amplex Red was prepared by dissolving Amplex Red reagent in dimethyl sulfoxide (DMSO). Several stock solutions were prepared according to the assay kit instructions. Horseradish Peroxidase (HRP) stock solution (10 U/ml) was prepared by dissolving HRP powder in 1X reaction buffer.
M17 neuroblastoma cells were seeded into black well/clear bottom 96-wells plate at 25,000 cells/ well (Corning Costar). Concentrations of each treatment were prepared and 50 μl of each treatment was added to the wells. The reaction was initiated by the addition of 50 μl of a working solution that contained 0.1 mM Amplex Red reagent and 0.2 U/ml HRP in 1X reaction buffer. This resulted in a final concentration of 50 μM Amplex Red reagent and 0.1 U/ml of HRP along with the various treatments in the reaction mix with a final reaction volume of 100 μl per well. Using a 544 nm excitation and a 590 nm emission, fluorescence was measured kinetically every 30 sec for 30 min using a FlexStation II 384 plate reader (Molecular Devices, Sunnyvale, CA). Results were analyzed by the Softmax Pro V5 software.
JC-1 assay (inner mitochondrial membrane potential , ∆Y m )
Membrane potential across the inner mitochondrial membrane was estimated using the fluorescent indicator dye JC-1 (Invitrogen). M17 neuroblastoma cells were seeded into black well/clear bottom 96-well plate at 25,000 cells/well, followed by incubation of Ab (1 nM), zinc (5 µM), DHA (30 µM) or CoQ10 (10 µM) alone and in combination for 24 h. Stock solution of JC-1 was made up by dissolving JC-1 powder in DMSO at a final concentration of 5 mg/ml (kept in -20°C). For a working solution, an aliquot of JC-1 dye was diluted in 1:25 OptiMem media. 5 µl of the working solution was added to each well and incubated in the dark for 10 min at 37°C. Cells were washed three times with 1x phosphate buffered saline (PBS). 100 µl of clear
Results
Aβ induces mitochondrial dysfunction in M17 neuroblastoma cells, which is restored by
CoQ10, but not DHA To examine whether DHA and CoQ10 could protect against Aβ-induced mitochondrial dysfunction in M17 neuroblastoma cells, we measured basal OCR as well as the combined OCR and ECAR response, which produce a bioenergetic function indicative of both mitochondrial respiration and glycolysis, respectively. Cell
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Aβ significantly reduced basal OCR when compared with control cells without altering basal ECAR (Fig. 1A) , indicating mitochondrial dysfunction without stimulating compensatory glycolysis. A reduction of OCR in response to Aβ treatment was restored by both CoQ10 alone and in combination with DHA (Fig. 1B) . However, DHA alone did not directly restore Aβ-mediated alteration in basal OCR (Fig. 1B) . Similar results were observed for mitochondrial respiration due to ATP turnover (Fig. 1C) , uncoupled respiration (proton leak) (Fig. 1D ) and maximal respiratory capacity (Fig. 1E) .
Zinc impairs mitochondrial bioenergetic function in M17 neuroblastoma cells, which is restored by CoQ10 and DHA, alone and in combination
There was a significant zinc-induced decrease of the basal mitochondrial respiration in M17 cells without alteration in glycolytic rate ( Fig. 2A) . A significant reduction of OCR in response to zinc treatment was restored by CoQ10 and DHA, alone and in combination (Fig. 2B) . The decrease in ATP turnover rate (Fig. 2C) , and maximal respiratory capacity (Fig. 2E) , were also restored by DHA and CoQ10, either alone or in combination. A decrease in uncoupled respiration was observed in zinc-treated cells, which was restored with either DHA alone and in combination with CoQ10. CoQ10 alone did not significantly affect uncoupled respiration (Fig. 2D) . and CoQ10 could protect against oxidative stress induced by Aβ and high physiological levels of zinc. We found that Aβ did not affect ROS production when compared to the control cells (Fig. 4A) , whereas zinc induced a small but statistically significant increase in H 2 O 2 levels in M17 neuroblastoma cells (Fig. 4B) . However, both DHA and CoQ10, as potent antioxidants, have shown to inhibit H 2 O 2 production (Figs. 4A and 4B ).
Discussion
Aβ and zinc impair basal respiration without alteration in glycolytic rate
To identify the mode of action of both CoQ10 and DHA on Aβ-and zinc-mediated bioenergetic alterations, we measured oxygen consumption rate in M17 cells using the Seahorse extracellular flux analyzer. We observed a significant reduction in basal respiration without alteration in glycolytic rate following exposure to Aβ and zinc.
Aβ and zinc treatments lead to impaired cellular bioenergetics and mitochondrial function
Our data show that there are significant reductions in basal respiration, mitochondrial ATP turnover rate, uncoupled respiration and maximal respiratory capacity following Aβ and zinc treatments. This defect of the whole mitochondrial respiratory chain may possibly be due to the accumulated dysfunction of one or several mitochondrial chain complexes as a result of mitochondrial Aβ, as well as zinc uptake.
Regardless of the dysfunctional features of end-stage cell death, mitochondrial membrane permeabilization is frequently the decisive event between cell survival and death [13, 25] . Therefore, to further unravel the effect of Aβ and zinc on mitochondrial respiratory dysfunction, we measured potential proxy of ∆Ψ m and ROS production in M17 cells. Our study showed the depletion of ∆Ψ m following Aβ and zinc treatment. We suggest that these Aβ-induced alterations in mitochondrial function are due to the ability of Aβ to permeabilize cellular membrane and therefore enter the mitochondria. A recent study by Pagani and Eckert (2011) has reported the deposition of Aβ in the outer and inner mitochondrial membrane [26] , which may explain the increase in membrane permeability. In the outer membrane, Aβ may be present at the site where it could influence the interaction between mitochondria and anti-apoptotic marker Bcl-2 [26] . However, in the inner membrane, Aβ may interact with the important components of enzymatic activity, metabolic or antioxidant mechanisms and therefore inhibit their actions [26] . These interactions of Aβ would then affect mitochondrial respiration that would potentially impair cellular metabolism. Aβ has been shown to directly inhibit complex IV, but increase in complex III [27] , which lead to bioenergetic impairment [13] . Taken together, our results suggest that following a decrease in ∆Ψ m and in uncoupled respiration, which results in a futile proton cycle, Aβ exhibit an initial defect in mitochondrial function. This may be caused by inhibition of complex IV activity that is translated into a mitochondrial respiration deficiency with diminished ATP synthesis, which cannot be compensated by an increased activity of complex III.
Apart from decreased ATP turnover rate, maximal respiratory capacity and uncoupled respiratory, high physiological level of zinc has been reported to inhibit electron transfer [28] , which could result in dissipation of ∆Ψ m , as observed in this study. This loss of ∆Ψ m contributes to the decrease in ∆Ψ m , which has been reported to be associated with release of cytochrome c and apoptosis-inducing factor (AIF) [9] . Aβ did not have much effect on ROS production, whereas zinc significantly increased ROS production, which indicates that zinc directly caused oxidative stress in neuronal cells leading to mitochondrial dysfunction. Zinc has also been shown to instigate H 2 O 2 production through tricarboxylic acid cycle (TCA) inhibition [29] . It is clear that zinc-mediated neuronal injury requires the mobilization and redistribution of zinc in the brain. Therefore, the strategies that prevent excessive zinc entry into the cells could ameliorate zinc-mediated cell death [30] . Sadli 
DHA may be directly protective against zinc-induced mitochondrial dysfunction, but not towards Aβ toxicity
Recently, we have reported that DHA could protect against zinc-altered mitochondrial dysfunction in M17 cells [10] . Part of this effect could be due to the neuroprotective function of DHA in limiting cellular zinc uptake through decreasing ZnT-3 zinc transporter expression levels [6, 20] , which in turn inhibits zinc toxicity. Our data show the ability of DHA to restore zinc-induced alteration in ∆Ψ m and H 2 O 2 production. We believe that these effects are due to the neuroprotective effect of DHA against zinc-induced ROS production caused by oxidative stress, which therefore indirectly stabilizes ∆Ψ m .
We observed that DHA alone did not significantly restore Aβ-mediated defects in the mitochondrial parameters assessed in this study. However, co-incubations of DHA in the presence of CoQ10 significantly restored Aβ-induced alterations to the same extent as CoQ10 treatment alone. From these results, we suggest that DHA alone was not directly protective against Aβ-induced mitochondrial dysfunction.
The effect of CoQ10 against Aβ-and zinc-induced alteration in mitochondrial physiology
In this study, we observed that CoQ10 could also interact with zinc and restore zincmediated cellular dysfunction. Our finding is supported by a recent study that a decrease in CoQ10 and increase in zinc levels were observed in chronic obstructive pulmonary disease (COPD) patients [31] , which probably result from the defense response of organism against zinc-mediated inflammation. There is no direct evidence in relation to zinc and CoQ10 interactions, but our results suggest that CoQ10 may be neuroprotective against zincinduced mitochondrial dysfunction. Our data also show that CoQ10 restores Aβ-induced alteration in membrane potential in neuronal cells, which is possibly caused by the ability of CoQ10 to inhibit the opening of mitochondrial permeability transition pore due to Aβ toxicity and therefore stabilize the membrane [14] . CoQ10 has also been reported to inhibit the aggregation of Aβ and therefore prevent its toxicity [32] . This indicates a direct antiamyloidogenic effect of CoQ10 in neuronal cells.
Conclusion
This study presents novel findings on the effects of CoQ10 and DHA against Aβ-and zinc-mediated bioenergetic alterations in M17 human neuroblastoma cells. Our results have shown that CoQ10 may have direct effect on Aβ-induced alteration in mitochondrial function, while DHA has no significant effect against Aβ toxicity. On the other hand, DHA, due to its direct molecular interaction with zinc [6, 20, 33] , may protect against zincmediated mitochondrial dysfunction. CoQ10, however, has also shown to restore zincinduced alteration in mitochondrial physiology to the same extent as DHA, suggesting the neuroprotective effect of CoQ10 against zinc toxicity.
Taken together, the results of our study indicates the potential of dietary benefits of DHA and CoQ10 for zinc-and Aβ-induced neuronal cell apoptosis, respectively, which is characteristic of neurodegenerative diseases such as Alzheimer's disease.
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